Company Overview
Snapshot
Founded in August 2012 by Tal Givoly and Dr. Steven Kaplan, Medivizor operates with 1-10 employees. The company's platform provides personalized medical science to patients, caregivers, and doctors. In August 2020, Medivizor partnered with MedEvoke to enhance clinical trial recruitment.
Business overview
Medivizor is a Health Tech & Life Sciences company focused on supporting patients with serious or chronic illnesses. Its patented, award-winning platform delivers current, trusted, and personally relevant medical science in an understandable and actionable format. Medivizor serves healthcare providers, patient advocacy organizations, and the biopharmaceutical industry, enabling patient education, engagement, and recruitment for clinical trials and direct-to-consumer marketing.
Strategic signal
In August 2020, Medivizor announced a multi-year agreement with MedEvoke to streamline clinical trial recruitment. This partnership is significant as it leverages Medivizor's patient communities and personalized content with MedEvoke's analytics to improve patient recruitment and retention in clinical research studies. This collaboration signals Medivizor's strategic expansion into supporting pharmaceutical and biotechnology clients, enhancing its value proposition beyond direct patient engagement by addressing a critical need in drug development.
Log in to access full profile ›Company Intelligence Q&A
- What is Medivizor's core offering?
- Medivizor provides a patented platform that delivers current, trusted, and personally relevant medical science to patients, their caregivers, and doctors, focusing on those with serious or chronic illnesses.
- When was Medivizor founded and by whom?
- Medivizor was founded in August 2012 by Tal Givoly and Dr. Steven Kaplan.
- What significant partnership did Medivizor announce in August 2020?
- In August 2020, Medivizor announced a multi-year collaboration agreement with MedEvoke to streamline clinical trial recruitment efforts for pharmaceutical, biotechnology, and medical device clients.
- What was Medivizor's involvement with IBM Alpha Zone?
- Medivizor participated in the IBM Alpha Zone corporate accelerator program, graduating in April 2018 after joining in June 2017.
- How does Medivizor assist the biopharmaceutical industry?
- Medivizor helps the biopharmaceutical industry reach and engage patients for recruitment into clinical trials, direct-to-consumer marketing, and insights in a cost-effective manner.